அலி டேயர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அலி டேயர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அலி டேயர் Today - Breaking & Trending Today

Bristol Myers Squibb and Acceleron Present First Results from Phase 2 BEYOND Study of Reblozyl® in Adults with Non-Transfusion Dependent Beta Thalassemia


Reblozyl
was generally well tolerated and improvements in hemoglobin correlated with improved patient-reported outcomes over a continuous 12-week interval
In the study, 89.6% of patients treated with Reblozyl
remained transfusion free vs. 67.3% of patients in the placebo arm at weeks 1-24
Results featured in Presidential Symposium of European Hematology Association’s Virtual Congress as one of top six abstracts submitted
Bristol Myers Squibb (NYSE: BMY) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced the first data from the Phase 2 BEYOND study evaluating
Reblozyl
®
(luspatercept-aamt), a first-in-class erythroid maturation agent, plus best supportive care in adult patients with non-transfusion dependent (NTD) beta thalassemia, were presented at the European Hematology Association (EHA) 2021 Virtual Congress as part of its Presidential Symposium (Abstract #S101). Results demonstrated that 77.7% of patients treated wi ....

United States , Nina Goworek , Ali Taher , Origar Beta , Noah Berkowitz , Bristol Myers Squibb , Jamie Bernard , American University Of Beirut , Hematology Development , European Hematology Association , Bristol Myers Squibb Company , European Union , Virtual Congress , Exchange Commission , Acceleron Pharma Inc , Presidential Symposium , Myers Squibb , Acceleron Pharma , American University , Habib Dable , Chief Executive Officer , Bristol Myers , Prescribing Information , Product Characteristics , Better Future , Social Media ,